03:23 AM EST, 11/06/2025 (MT Newswires) -- Sean Maduck, President, Corcept Endocrinology, on November 03, 2025, sold 20,000 shares in Corcept Therapeutics ( CORT ) for $1,479,816. Following the Form 4 filing with the SEC, Maduck has control over a total of 117,621 common shares of the company, with 7,904 shares held directly and 109,717 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1088856/000119312525267542/xslF345X05/ownership.xml